ArticleTranslational lung cancer research2022

Macrophages-based immune-related risk score model for relapse prediction in stage I-III non-small cell lung cancer assessed by multiplex immunofluorescence.

Xiang-Rong Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.